|
1
|
Liang X, Bi S, Yang W, Wang L, Cui G, Cui
F, Zhang Y, Liu J, Gong X, Chen Y, et al: Epidemiological
serosurvey of hepatitis B in China-declining HBV prevalence due to
hepatitis B vaccination. Vaccine. 27:6550–6557. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
el-Serag HB: Epidemiology of
hepatocellular carcinoma. Clin Liver Dis. 5:87–107. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wright TL and Lau JY: Clinical aspects of
hepatitis B virus infection. Lancet. 342:1340–1344. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen J, Eslick GD and Weltman M:
Systematic review with meta-analysis: Clinical manifestations and
management of autoimmune hepatitis in the elderly. Aliment
Pharmacol Ther. 39:117–124. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Aleman S, Rahbin N, Weiland O,
Davidsdottir L, Hedenstierna M, Rose N, Verbaan H, Stål P, Carlsson
T, Norrgren H, et al: A risk for hepatocellular carcinoma persists
long-term after sustained virologic response in patients with
hepatitis C-associated liver cirrhosis. Clin Infect Dis.
57:230–236. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Angeli P, Sanyal A, Moller S, Alessandria
C, Gadano A, Kim R, Sarin SK and Bernardi M: International Club of
Ascites: Current limits and future challenges in the management of
renal dysfunction in patients with cirrhosis: Report from the
International Club of Ascites. Liver Int. 33:16–23. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sharara AI, Hunt CM and Hamilton JD:
Hepatitis C. Ann Intern Med. 125:658–668. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Masuzaki R, Tateishi R, Yoshida H, Goto E,
Sato T, Ohki T, Imamura J, Goto T, Kanai F, Kato N, et al:
Prospective risk assessment for hepatocellular carcinoma
development in patients with chronic hepatitis C by transient
elastography. Hepatology. 49:1954–1961. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Castéra L, Vergniol J, Foucher J, Le Bail
B, Chanteloup E, Haaser M, Darriet M, Couzigou P and De Lédinghen
V: Prospective comparison of transient elastography, Fibrotest,
APRI, and liver biopsy for the assessment of fibrosis in chronic
hepatitis C. Gastroenterology. 128:343–350. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Colletta C, Smirne C, Fabris C, Toniutto
P, Rapetti R, Minisini R and Pirisi M: Value of two noninvasive
methods to detect progression of fibrosis among HCV carriers with
normal aminotransferases. Hepatology. 42:838–845. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Degos F, Perez P, Roche B, Mahmoudi A,
Asselineau J, Voitot H and Bedossa P: FIBROSTIC study group:
Diagnostic accuracy of FibroScan and comparison to liver fibrosis
biomarkers in chronic viral hepatitis: A multicenter prospective
study (the FIBROSTIC study). J Hepatol. 53:1013–1021. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sebastiani G, Halfon P, Castera L, Pol S,
Thomas DL, Mangia A, Di Marco V, Pirisi M, Voiculescu M, Guido M,
et al: SAFE biopsy: A validated method for large-scale staging of
liver fibrosis in chronic hepatitis C. Hepatology. 49:1821–1827.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bonder A and Afdhal NH: Biopsy no more;
changing the screening and diagnostic algorithm for hepatitis C.
Clin Gastroenterol Hepatol. 11:309–310. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Foucher J, Chanteloup E, Vergniol J,
Castéra L, Le Bail B, Adhoute X, Bertet J, Couzigou P and de
Lédinghen V: Diagnosis of cirrhosis by transient elastography
(FibroScan): A prospective study. Gut. 55:403–408. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nguyen-Khac E, Chatelain D, Tramier B,
Decrombecque C, Robert B, Joly JP, Brevet M, Grignon P, Lion S, Le
Page L and Dupas JL: Assessment of asymptomatic liver fibrosis in
alcoholic patients using Fibroscan: Prospective comparison with
seven non-invasive laboratory tests. Aliment Pharmacol Ther.
28:1188–1198. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mueller S, Millonig G, Sarovska L,
Friedrich S, Reimann FM, Pritsch M, Eisele S, Stickel F, Longerich
T, Schirmacher P and Seitz HK: Increased liver stiffness in
alcoholic liver disease: Differentiating fibrosis from
steatohepatitis. World J Gastroenterol. 16:966–972. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Obara N, Ueno Y, Fukushima K, Nakagome Y,
Kakazu E, Kimura O, Wakui Y, Kido O, Ninomiya M, Kogure T, et al:
Transient elastography for measurement of liver stiffness
measurement can detect early significant hepatic fibrosis in
Japanese patients with viral and nonviral liver diseases. J
Gastroenterol. 43:720–728. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Vergniol J, Foucher J, Mamou K, Castéra L,
Bernard PH, Couzigou P and de Lédinghen V: Non-invasive evaluation
of liver fibrosis using FibroScan in long-term
sustained-virological responder patients after HCV treatment.
Gastroenterol Clin Biol. 32:1061–1063. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang JH, Changchien CS, Hung CH, Tung WC,
Kee KM, Chen CH, Hu TH, Lee CM and Lu SN: Liver stiffness decrease
after effective antiviral therapy in patients with chronic
hepatitis C: Longitudinal study using FibroScan. J Gastroenterol
Hepatol. 25:964–969. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Marcellin P, Ziol M, Bedossa P, Douvin C,
Poupon R, de Lédinghen V and Beaugrand M: Non-invasive assessment
of liver fibrosis by stiffiness measurement in patients with
chronic hepatitis B. Liver Int. 29:242–247. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tsochatzis EA, Gurosamy KS, Ntaoula S,
Cholongitas E, Davidson BR and Burroughs AK: Elastography for the
diagnosis of severity of fibrosis in chronic liver disease: A
meta-analysis of diagnostic accuracy. J Hepatol. 54:650–659. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sagir A, Erhardt A, Schmitt M and
Häussinger D: Transient elastography is unreliable for detection of
cirrhosis in patients with acute liver damage. Hepatology.
47:592–595. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fildes R: Conditioning diagnostics:
Collinearity and weak data in regression. Technometrics. 35:85–86.
1993. View Article : Google Scholar
|
|
24
|
Tana MM, Zhao X, Bradshaw A, Moon MS, Page
S, Turner T, Rivera E, Kleiner DE and Heller T: Factors associated
with the platelet count in patients with chronic hepatitis C.
Thromb Res. 135:823–828. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lu SN, Wang JH, Liu SL, Hung CH, Chen CH,
Tung HD, Chen TM, Huang WS, Lee CM, Chen CC and Changchien CS:
Thrombocytopenia as a surrogate for cirrhosis and a marker for the
identification of patients at high-risk for hepatocellular
carcinoma. Cancer. 107:2212–2222. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Henderson NC and Iredalc JP: Liver
fibrosis: Cellular machanisms of progression and resolution. Clin
Sci (Lond). 112:265–280. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cournane S, Browne JE and Fagan AJ: The
effects of fatty deposits on the accuracy of the
Fibroscan® liver transient elastography ultrasound
system. Phys Med Biol. 57:3901–3914. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tapper EB, Cohen EB, Patel K, Bacon B,
Gordon S, Lawitz E, Nelson D, Nasser IA, Challies T and Afdhal N:
Levels of alanine aminotransferase confound use of transient
elastography to diagnose fibrosis in patients with chronic
hepatitis C virus infection. Clin Gastroenterol Heaptol.
10:932–937.e1. 2012. View Article : Google Scholar
|
